# Ttt of Adenomyosis

> **NCT06719934** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Al-Azhar University** · enrollment: 100 (estimated)

## Conditions studied

- Adenomyosis

## Interventions

- **DRUG:** Dienogest 2 mg orally
- **PROCEDURE:** UAE

## Key facts

- **NCT ID:** NCT06719934
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06719934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06719934, "Ttt of Adenomyosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06719934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*